Advanced Search

Technical Analysis for REPL - Replimune Group, Inc.

Grade Last Price % Change Price Change
grade C 21.55 7.91% 1.58
REPL closed up 7.91 percent on Monday, August 3, 2020, on 76 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
1 Watcher
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up
Historical REPL trend table...
Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Multiple of Ten Bullish Other 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.91%
Pocket Pivot Bullish Swing Setup 7.91%
Multiple of Ten Bearish Other 7.91%
Inside Day Range Contraction 7.91%
Multiple of Ten Bearish Other 8.02%
Oversold Stochastic Weakness 8.02%
Bullish Engulfing Bullish 7.80%
Older EOD signals for REPL ...
View Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP, RP2, and RP3. The Company is focused on Phase 1/2 clinical trial with its lead product candidate, RP1, in approximately 150 patients with a range of solid tumors.
Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Solid Tumors Cancer Treatments Virotherapy Experimental Cancer Treatments Transgene Sa

Is REPL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 22 Replimune Appoints Andrea Pirzkall, M.D. as Chief Medical Officer
Jun 30 The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
Jun 26 The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Jun 22 Replimune Group, Inc. (REPL): Hedge Funds Are Reducing Exposure
Jun 17 Replimune to Participate at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
Jun 11 Replimune (REPL) Looks Good: Stock Adds 5.8% in Session
Jun 9 The Daily Biotech Pulse: Soleno Flunks Late-Stage Study, Sanofi Strikes Breast Cancer Partnership, NanoViricides Shortlists Coronavirus Treatment Candidates
Jun 9 Replimune prices $100M share-offering
Jun 9 Replimune Announces Pricing of Upsized Public Offering
Jun 8 Replimune dips ~8% on proposed public offering
See more REPL news...

Indicators

Indicator Value
52 Week High 26.22
52 Week Low 8.58
Average Volume 247,927
200-Day Moving Average 16.50
50-Day Moving Average 21.48
20-Day Moving Average 21.21
10-Day Moving Average 20.02
Average True Range 1.40
ADX 18.71
+DI 23.27
-DI 22.66
Chandelier Exit (Long, 3 ATRs ) 19.83
Chandelier Exit (Short, 3 ATRs ) 22.61
Upper Bollinger Band 24.07
Lower Bollinger Band 18.36
Percent B (%b) 0.56
BandWidth 26.93
MACD Line -0.47
MACD Signal Line -0.36
MACD Histogram -0.1042
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.89
Resistance 3 (R3) 23.63 22.59 23.50
Resistance 2 (R2) 22.59 21.99 22.72 23.37
Resistance 1 (R1) 22.07 21.63 22.33 22.33 23.24
Pivot Point 21.03 21.03 21.16 21.16 21.03
Support 1 (S1) 20.51 20.43 20.77 20.77 19.86
Support 2 (S2) 19.47 20.07 19.60 19.73
Support 3 (S3) 18.95 19.47 19.60
Support 4 (S4) 19.21